Guard Therapeutics announced that Ann-Kristin Myde has been appointed new Head of Global Project Management for the company. She will take up her post on 1 April 2021. As Head of Global Project Management, Ann-Kristin Myde will be part of Guard Therapeutics' management team and report to the company's CEO. Ann-Kristin Myde has a B.SC. in Biochemistry from Stockholm University and more than 30 years' experience from the pharmaceutical industry, where she has held a number of senior positions in project management, business development and marketing at players such as AstraZeneca and Thermo Fisher. Before joining Guard Therapeutics, she worked at Calliditas Therapeutics where she was in charge of clinical development and project management in renal medicine.